Last reviewed · How we verify
Track B
Track B is a medication that works by inhibiting the reuptake of certain neurotransmitters.
Track B is a medication that works by inhibiting the reuptake of certain neurotransmitters. Used for Major depressive disorder, Obsessive-compulsive disorder.
At a glance
| Generic name | Track B |
|---|---|
| Also known as | Placebo control group, Refresh Tears |
| Sponsor | ATS Clinical Research |
| Drug class | Selective serotonin reuptake inhibitor |
| Target | Serotonin transporter |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | FDA-approved |
Mechanism of action
This leads to increased levels of these neurotransmitters in the brain, which can help improve mood and reduce symptoms of depression. However, the exact mechanism of action is not fully understood and may involve other pathways as well.
Approved indications
- Major depressive disorder
- Obsessive-compulsive disorder
Common side effects
- Nausea
- Headache
- Dizziness
- Insomnia
- Fatigue
Key clinical trials
- MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence (NA)
- Mindfulness Intervention on Minimally Invasive Vascular Surgery (NA)
- STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision (NA)
- Effects of Accentuated Eccentric Versus Concentric Training in Fast Bowlers (NA)
- Self-management Program in Patients With COPD (NA)
- Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use (NA)
- Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment (PHASE3)
- TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Track B CI brief — competitive landscape report
- Track B updates RSS · CI watch RSS
- ATS Clinical Research portfolio CI